Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-12

FDA Approved: CAVERJECT — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for CAVERJECT (alprostadil) by Pharmacia & Upjohn Company LLC. The snippet does not specify the exact changes to lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAVERJECT (ALPROSTADIL)

Snippet

SUPPL AP for CAVERJECT (ALPROSTADIL)